and categorical outcomes were studied using chi-square or Fisher's exact test. The Wilcoxon test was used for continuous outcomes. Survival outcomes were studied using log-rank test or cox regression model. Results: Of 1,113 pts identified, 417 pts had complete irAE data: 156 pts with melanoma, 117 pts with NSCLC, 33 pts with RCC, and 111 pts with other cancers. irAEs occurred in 120/417 pts (28.78%). Gender, age at treatment, and smoking history were not associated with irAE. Incidence of pneumonitis and colitis were 3.84% and 6%, respectively. Pneumonitis was more common in NSCLC (p ¼ 0.004), and colitis was more common in melanoma (p ¼ 0.016). Rates of thyroid, hepatic, and neurologic irAE were 5.29%, 4.08%, and 0.84%. irAEs were associated with length of therapy (p ¼ 0.021), and were more common in 29 pts treated with combination ICI (p < 0.001). For 366 pts with metastatic disease, irAEs were associated with longer survival: median OS 21.1 months vs 9.2 months (HR ¼ 0.48, 95% CI: 0.35 -0.66, p < 0.001). Thyroid toxicity (HR ¼ 0.25, 95% CI: 0.10 -0.29, p ¼ 0.002) and hepatitis (HR ¼ 0.32, 95% CI: 0.12 -0.85, p ¼ 0.023) were associated with longer OS. Conclusions: Increased awareness of irAE patterns across different cancer and treatment types will allow for rapid identification and treatment of irAE. Legal entity responsible for the study: The Ohio State University. Background: Prior studies suggest the benefits of yoga in maintaining Diabetes and Hypertension. In this study we aim to evaluate the effect of yoga on ChemoRadiotherapy induced Diabetes and Hypertension (CRID-H) in cervical cancer patients. Methods: 60 cervical cancer subjects (stage II -IV) undergoing chemo-radiation therapy were randomized into yoga (n ¼ 30) and control group (n ¼ 30). Yoga group was given loosening, breathing, chanting and meditation for 5 days/ week for 6 weeks. Weekly assessment of Random Blood Sugar and blood pressure was recorded from baseline to discharge. Appropriate statistical analysis was conducted. Results: 6 yoga and 6 non-yoga patients were found to be known case of hypertension and on medications. During the course of chemo-radiation 4 yoga and 6 non-yoga patients developed hypertension. The systolic pressure among the yoga group remained constant with a mean difference of just 11.3mm of Hg while non-yoga group recorded 37.2mm of Hg Comparative analysis between the two groups show Systolic BP attained significance of p ¼ 0.3 and Diastolic BP, p ¼ 0.11. Diastolic BP in non-hypertensive patients of yoga group (p ¼ 0.01) achieved good significance while hypertensive patients (p ¼ 0.14) and all patients (p ¼ 0.11) the results incline towards significance. Thus, yoga is effective to maintain BP among non-hypertensive patients and attain moderate control in hypertensive ones. RBS data reveals 5 yoga and 6 non-yoga subjects had pre-existing diabetes. 4 yoga and 6 non-yoga subjects developed diabetes with chemo-radiation by the 3rd week of treatment. Good significance was achieved between the two groups as a whole (p ¼ 0.02). The difference was highly significant at p ¼ 0.009 among pre-existing diabetic patients. Conclusions: Adjuvant yoga therapy helps to control CRID-H in cervical cancer efficiently. The control achieved in RBS is highly significant. Considerable effect in hypertension was also observed. The above direction can be employed in future studies with larger sample size. Acknowledgement-Ministry of AYUSH, Government of India.
1773P Effect of yoga on chemo-radiotherapy induced diabetes and hypertension (CRID-H) among cervical cancer patients at a regional cancer institute in south India Background: Prior studies suggest the benefits of yoga in maintaining Diabetes and Hypertension. In this study we aim to evaluate the effect of yoga on ChemoRadiotherapy induced Diabetes and Hypertension (CRID-H) in cervical cancer patients. Methods: 60 cervical cancer subjects (stage II -IV) undergoing chemo-radiation therapy were randomized into yoga (n ¼ 30) and control group (n ¼ 30). Yoga group was given loosening, breathing, chanting and meditation for 5 days/ week for 6 weeks. Weekly assessment of Random Blood Sugar and blood pressure was recorded from baseline to discharge. Appropriate statistical analysis was conducted. Results: 6 yoga and 6 non-yoga patients were found to be known case of hypertension and on medications. During the course of chemo-radiation 4 yoga and 6 non-yoga patients developed hypertension. The systolic pressure among the yoga group remained constant with a mean difference of just 11.3mm of Hg while non-yoga group recorded 37.2mm of Hg Comparative analysis between the two groups show Systolic BP attained significance of p ¼ 0.3 and Diastolic BP, p ¼ 0.11. Diastolic BP in non-hypertensive patients of yoga group (p ¼ 0.01) achieved good significance while hypertensive patients (p ¼ 0.14) and all patients (p ¼ 0.11) the results incline towards significance. Thus, yoga is effective to maintain BP among non-hypertensive patients and attain moderate control in hypertensive ones. RBS data reveals 5 yoga and 6 non-yoga subjects had pre-existing diabetes. 4 yoga and 6 non-yoga subjects developed diabetes with chemo-radiation by the 3rd week of treatment. Good significance was achieved between the two groups as a whole (p ¼ 0.02). The difference was highly significant at p ¼ 0.009 among pre-existing diabetic patients. Conclusions: Adjuvant yoga therapy helps to control CRID-H in cervical cancer efficiently. The control achieved in RBS is highly significant. Considerable effect in hypertension was also observed. The above direction can be employed in future studies with larger sample size. Acknowledgement-Ministry of AYUSH, Government of India. Legal entity responsible for the study: Ministry of Ayush, Government of India. Funding: Has not received any funding. Disclosure: All authors have declared no conflicts of interest. Background: Fatigue is a common symptom reported by cancer patients (pts) and has been previously documented to affect patient's quality of life. Methods: A real-world data survey was designed to evaluate, from the pts perspective, the fatigue effect and treatment adherenceA survey was created in a digital format. This was sent randomly and replied anonymously by users of the Belong app a dedicated social network for cancer pts and their caregivers. Belong leveraged both push notifications as well as DPROs (Digital patients reported outcome feature) which appeared on user's apps dashboards for their increased engagement. Results: 505 replies were received from pts (85%) and caregivers (15%). The data was then extracted from the digital platform and analysed. A statistical mathematical predictive model was utilized. A machine learning analytical model was programmed to obtain the results. The most common diagnoses were Breast Cancer (all stages, 34.5%), lung (10.1%) and colorectal cancer (7.7%). 67.1% of the pts were on active treatment at the time of the survey and 11.5% finished the treatment less than 6 months before. 66% of the pts experienced daily fatigue (described as mild, moderate and severe) and 17.2% experienced it weekly. As a direct result of fatigue, 10.1% of all pts reported that their ongoing treatments were delayed, stopped or changed (poor adherence). 137 (27%) of the total number of replies (mainly advanced breast and lung cancers pts) reported severe fatigue and 19% of them confirmed poor treatment adherence. However, better adherence was seen in the subgroup of pts which experienced mild to moderate fatigue.
Conclusions: This survey describes the prevalence and adverse impact of severe fatigue present in certain cancer pts subgroups (advanced breast and lung cancers) which can alter significantly their adherence to planned treatments. Uniquely, while poor treatment adherence was observed in some cancer diagnosis, most of patients who experienced mild to moderate fatigue maintained their treatment schedule. Effective strategies and efforts should aim to solve this common side effect and its deleterious consequences.
Legal entity responsible for the study: The authors. Background: There is a widespread belief that Euthanasia and good palliative medicine are mutually exclusive. It is important to explore whether the philosophy of palliative medicine which lays an emphasis on a good death also recognizes the individual's right to seek death as a means to end suffering. Methods: A survey exploring the attitude and opinion of respondents on the extent of involvement of Palliative/Supportive medicine professionals in the provision of Euthanasia was conducted among the registered delegates of Indian association of Palliative Care conference 2018. Results: 55.66 percent (85/153) of the respondents agreed that the debate on Euthanasia was within the purview of Palliative Medicine, while 52.71 percent (78/148) agreed that the provision of Euthanasia was within End of Life care. 61.27 percent (87/ 152) of the respondents believe that a set of multidisciplinary experts should be introduced to initiate the discussion on Euthanasia in a terminally ill patient when the same is expressly demanded by the patient or family members. A majority (37.68 percent -52/138) disagreed with the use of the terms Passive and Active euthanasia. A majority of the respondents (51.74 percent -74/143) also strongly disagreed with the use of the term physician assisted suicide. 42.46 percent (62/146) of the individuals agreed that the right to a good death and Euthanasia were mutually exclusive. 40.13 percent (61/ 152) agreed that they do not recognize the right to Euthanasia. Conclusions: The right to seek Euthanasia as a means of a respectable death is a debatable subject which should be approached carefully keeping in mind the distinct sociopoliticocultural thread which runs through the moral fiber of each society. The involvement of experts from multiple subspecialities (as suggested by the highest court of law in India) while ignoring the pivotal role of the palliative medicine professional in establishing a framework of guidelines surrounding Euthanasia does not seem to be justified. The importance of having the tenets of law firmly on their side should not be underestimated by Palliative/supportive medicine professionals who are bound by duty to take the lead in the discourse surrounding End of life care. Legal entity responsible for the study: Rahul D. Arora. Funding: Has not received any funding. Disclosure: The author has declared no conflicts of interest.
1776P Acute toxicity of concurrent radiochemotherapy for locally advanced head and neck cancer: A prospective study Background: Concurrent chemoradiation (CCRT) is the standard treatment for patients with inoperable locoregionally advanced squamous cell carcinoma of the head and neck (HNSCC). CCRT can be associated with severe acute toxicity. Usually only the maximum grade of a limited selection of adverse events (AEs) is reported, without mentioning the evolution of toxicity over time. By the lack of the time factor, the global burden of toxicity experienced by the patient is not adequately reflected. 
